| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2021 | Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activity | Ho, KW; Chen, IU; Cheng, YA; Liao, TY; Liu, ES; Chen, HJ; Lu, YC; Su, YC; Roffler, SR ; Huang, BC; Liu, HJ; Huang, MY; Chen, CY; Cheng, TL | Journal of nanobiotechnology 19, 16 | | | |
| 2017 | Enhancement Effect of a Variable Topology of a Membrane-Tethered Anti-Poly(ethylene glycol) Antibody on the Sensitivity for Quantifying PEG and PEGylated Molecules. | Lin, WW; Cheng, YA; Kao, CH; Roffler, SR ; Lee, YC; Chen, BM; Hsieh, YC; Chen, IJ; Huang, BC; Wang, YT; Tung, YC; Huang, MY; Chen, FM; Cheng, TL | ANALYTICAL CHEMISTRY 89(11), 6082-6090 | | | |
| 2014 | High-throughput sorting of the highest producing cell via a transiently protein-anchored system. | Chuang, KH; Hsieh, YC; Chiang, IS; Chuang, CH; Kao, CH; Cheng, TC; Wang, YT; Lin, WW; Chen, BM; Roffler, SR; Huang, MY; Cheng, TL | PloS one 9(7), e102569 | | | |
| 2022 | Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis | Cheng, KW; Tseng, CH; Chen, IJ; Huang, BC; Liu, HJ; Ho, KW; Lin, WW; Chuang, CH; Huang, MY; Leu, YL; Roffler, SR ; Wang, JY; Chen, YL; Cheng, TL | Pharmacological research 177, 106115 | | | |
| 2022 | Safety Assessment of 3S, 3'S Astaxanthin Derived from Metabolically Engineered K. marxianus | Samuel, SY; Wang, HD; Huang, MY; Cheng, YS; Chen, JR; Li, WH ; Chang, JJ | Antioxidants 11(11), 2288 | | | |
| 2009 | Solution-Phase Parallel Synthesis of Novel Spirooxazolinoisoxazolines | Shih, HW; Guo, CW; Lo, KH; Huang, MY; Cheng, WC. | J. Comb. Chem. 11(2), 281-287. | | | |
